1. ‘Bioavailability/bioequivalence regulations' an FDA perspective’, in (ed.), Drug Absorption and Disposition: Statistical Considerations, American Pharmaceutical Association, Academy of Pharmaceutical Sciences, 1980, p. 115.
2. ‘Bioequivalence: emerging policies and procedures’, presented at Drug Information Association, Hilton Head, SC, 1985.
3. Statistical Simulation Study of New Proposed Uniformity Requirement for Bioequivalency Studies